Hahn Maureen K, Blakely Randy D
Department of Pharmacology and Center for Molecular Neuroscience, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Annu Rev Pharmacol Toxicol. 2007;47:401-41. doi: 10.1146/annurev.pharmtox.47.120505.105242.
Solute carrier 6 (SLC6) is a gene family of ion-coupled plasma membrane cotransporters, including transporters of neurotransmitters, amino acids, and osmolytes that mediate the movement of their substrates into cells to facilitate or regulate synaptic transmission, neurotransmitter recycling, metabolic function, and fluid homeostasis. Polymorphisms in transporter genes may influence expression and activity of transporters and contribute to behavior, traits, and disease. Determining the relationship between the monoamine transporters and complex psychiatric disorders has been a particular challenge that is being met by evolving approaches. Elucidating the functional consequences of and interactions among polymorphic sites is advancing our understanding of this relationship. Examining the influence of environmental influences, especially early-life events, has helped bridge the gap between genotype and phenotype. Refining phenotypes, through assessment of endophenotypes, specific behavioral tasks, medication response, and brain network properties has also improved detection of the impact of genetic variation on complex behavior and disease.
溶质载体6(SLC6)是离子偶联质膜共转运蛋白的一个基因家族,包括神经递质、氨基酸和渗透溶质的转运蛋白,它们介导其底物进入细胞,以促进或调节突触传递、神经递质再循环、代谢功能和液体稳态。转运蛋白基因的多态性可能影响转运蛋白的表达和活性,并导致行为、性状和疾病。确定单胺转运蛋白与复杂精神疾病之间的关系一直是一项特殊挑战,而不断发展的方法正在应对这一挑战。阐明多态性位点的功能后果及其相互作用正在加深我们对这种关系的理解。研究环境影响,尤其是早期生活事件的影响,有助于弥合基因型和表型之间的差距。通过评估内表型、特定行为任务、药物反应和脑网络特性来细化表型,也提高了对遗传变异对复杂行为和疾病影响的检测能力。